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ABSTRACT
Phytosterol-rich fraction (PRF) obtained from palm fatty acid distillate
(PFAD) was investigated for its effect on blood serum lipid profile of
dyslipidemia rats. Dyslipidemia was induced by force feeding choles-
terol to five groups of rats; one group was a control or normal group.
Cholesterol force-fed groups were treated with 0, 10, 20, 30, and 40 mg
PRF/kg/day for 4 weeks. All groups of rats were fed standard diet. A nor-
mal group was fed standard diet without PRF treatment and choles-
terol force feeding. Lipid profile was measured every week (0, 1, 2, 3, and
4). Four-week treatment resulted in significant blood serum lipid pro-
file improvement. PRF improved blood serum lipid profile by decreasing
total cholesterol, triglyceride, and low density lipoprotein (LDL) choles-
terol level and increasing high density lipoprotein (HDL) cholesterol
level. The doses of PRF significantly affected blood serum lipid profile as
well as duration of PRF treatment. PRF inhibited cholesterol absorption,
which delayed blood serum total cholesterol rise. Cholesterol absorp-
tion inhibition was also indicated by higher fecal cholesterol concentra-
tion after PRF feeding. These results indicate the beneficial effect of PRF
in the treatment of dyslipidemia.
Introduction
Palm fatty acid distillate (PFAD) is a by-product of the physical refining of crude palm oil
in the deodorization step. In general, PFAD contains 80% to 90% of free fatty acid, some
unsaponifiable components, neutral lipid, glycerides, and other high-molecular-weight com-
pounds. For the past decade, PFAD has been used as a source of vitamin E, squalene, and
phytosterols for pharmaceutical and cosmetic industries (Gapor, 2010). Palm oil phytosterols
are composed of campesterol (13%), β sitosterol (60%), and stigmasterol (24%) (Loganathan
et al., 2009). Phytosterol composition did not change during the degumming and bleaching
process in palm oil refining (Puah et al., 2004). Goh and Gee (1985) reported that squalene
was the main component of PFAD hydrocarbons, with other minor components.
Phytosterols are a triterpene that have similar molecular structure to cholesterol, with four
steroid rings, and are classified as 3β-hydroxyl; they frequently have double bonds at 5 and
6 positions. Phytosterols stabilize the phospholipid bilayer in the cell membrane (Fernandes
and Cabral, 2007). Phytosterols can reduce total cholesterol as well as LDL cholesterol
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(Jones et al., 2000; Lichtenstein and Deckelbaum, 2001; Yang et al., 2004; Nguyen et al., 2009).
The hypocholesterolemic effect of phytosterols is related to cholesterol absorption inhibition.
Phytosterol supplementation at a dose of 2 g/day effectively reduced cholesterol absorption
in digestive tracts, thus reducing plasma total cholesterol to 10%, reducing LDL cholesterol
to 10%–15%, and preventing HDL cholesterol decrease, without causing malabsorption
(Jones et al., 2003). Quilez et al. (2003) also indicated that phytosterol intake of 1.5–3.0 g/day
decreased LDL cholesterol 8%–15%. The safety of phytosterols, phytostanols, and ester
phytosterols has been declared by the U.S. Food and Drug Administration and the European
Union Scientific Committee (Kritchevsky and Chen, 2005).
This research aimed to study the effect of PRF in blood serum lipid profile as well as the
suitable dose for lipid profile improvement. The mechanism of blood serum lipid profile
improvement was studied through cholesterol absorption inhibition and fecal cholesterol
concentration analysis.
Materials andmethods
Materials
PFAD was obtained from a palm oil refinery (PT Salim Ivomas Pratama) at Surabaya, East
Java, Indonesia. Standard diet was referred to AIN-93M (Reeves et al., 1993) and Wistar
male rats (Rattus norvegicus) had body weight of∼200 g. Pure cholesterol (Sigma Co., Singa-
pore) was used to induce dyslipidemia. Blood serum lipid profile was analyzed using Diasys-
Diagnostic Systems (GmBH and Co., Holzheim, Germany). Other chemical reagents were
used for PRF preparation (technical grade) and analysis (pro-analysis grade).
Phytosterol-rich fraction preparation
Phytosterol-rich fraction (PRF)was prepared according to themethod ofWardhana (2011) by
low temperature solvent crystallization. PRF was obtained from PFAD by saponification fol-
lowed by solvent crystallization. Saponification used potassiumhydroxide (KOH) in ethanolic
solution, and the unsaponifiablematter was extracted by hexane. After evaporation of hexane,
unsaponifiable matter was crystallized at low temperature (−10°C) by using hexane as a sol-
vent, and the white crystal formed was taken for further purification. The crystal fraction was
dissolved in hexane and recrystallized to obtain more pure crystal. This crystal was expressed
as phytosterol-rich fraction (PRF).
The PRF obtained and the original PFADwere analyzed for phytosterol concentration and
composition. Phytosterol analysis followed the method of Khatoon et al. (2010). About 1 mg
of unsaponifiable matter of PFAD was added to ethanol 1 ml and subsequently filtered; 20 μl
of sample solution was injected into high-performance liquid chromatography (Shimadzu
LC20AT)with columnVPODS (C18) 250× 4.6mmandUVvis detector (Shimadzu SPD20A)
at wavelength of 206 nm. The mobile phase was methanol:water (99:1 v:v) with a flow rate of
1 ml/min. Identification and quantification were conducted using phytosterols (stigmasterol,
β sitosterol, campesterol, Sigma Co) standard that was injected into HPLC separately. PRF
and PFAD were also analyzed for yield (%), free fatty acids (AOCS, 1990), peroxide value
(Hills and Thiel, 1946), and p-anisidin value (ISO, 2016).
Bioassay for lipid profile changes
Bioassay was performed using six groups of six rats in each group, except three rats per group
were used for cholesterol absorption inhibition test. Ratswere adapted to the environment and
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standard diet for a week and subsequently induced by cholesterol force feeding (1% based on
standard diet or 200 mg per rat) to obtain dyslipidemia condition. The normal group as a
control was not force fed cholesterol. All groups had free access to diet (ad libitum). Dyslipi-
demia condition (blood serum total cholesterol of >200 mg/dL; hypercholesterolemia) was
achieved after one week of cholesterol administration.
Rats were divided into six groups as follows: five groups of dyslipidemia rats were fed
AIN-93M standard diet and force fed PRF 0, 10, 20, 30, and 40 mg/kg/day diluted in 2 ml
of palm oil; the normal group was fed AIN-93Mwithout PRF force feeding. The test was con-
ducted for four weeks. Body weight of rats and blood serum lipid profiles were measured
every week after the rats were fasting for 16 hours. Blood was taken from the rats retro-
orbitally, and the blood was then centrifuged at 4,000 rpm for 15 min to separate serum and
plasma. The upper layer was taken and analyzed for total cholesterol, low-density lipopro-
tein (LDL) cholesterol, and high-density lipoprotein (HDL) cholesterol by enzymatic col-
orimetric test (CHOD-PAP) and triglyceride was measured by enzymatic colorimetric test
(GPO-PAP).
The colorimetric method of total cholesterol analysis was carried out according to Allain
et al. (1974), based on the formation of D4 cholestenone. Cholesterol was produced from
cholesterol ester by cholesterol esterase. Cholesterol was converted into D4 cholestenone
by cholesterol oxidase and released hydrogen peroxide. Hydrogen peroxide reacted with 4-
aminophenazone and 4-chlorophenol that catalyzed by peroxidase and formed color complex;
the absorbance was measured at 500 nm.
The colorimetric method of HDL cholesterol measurement was based on the method of
Seguchi et al. (1995). The apoB-containing lipoproteins in the specimen react with a blocking
reagent that renders them nonreactive with the enzymatic cholesterol reagent under condi-
tions of the assay. The apoB-containing lipoproteins are thus effectively excluded from the
assay and only HDL cholesterol is detected under the assay conditions. The method uses
sulfated alpha-cyclodextrin in the presence of Mg+2, which forms complexes with apoB-
containing lipoproteins, and polyethylene glycol-coupled cholesteryl esterase and cholesterol
oxidase for the HDL cholesterol measurement. Hydrogen peroxide liberated from a series of
enzymatic reactions of HDL cholesterol was reacted with 5-aminophenazone and N-ethyl-
N-(3-methylphenyl)-N’-succinyl ethylenediamine that was catalyzed by peroxidase to form
complex color that was measured at 600 nm. LDL cholesterol was calculated by diminish-
ing total cholesterol with HDL cholesterol and triglycerides (Nigam, 2011) with the following
equation:
LDL cholesterol = total cholesterol − HDL cholesterol− [triglycerides/5]
The principle of triglyceride analysis in the sample is that triglycerides are hydrolyzed by
lipase into glycerol and free fatty acids. Glycerol is then phosphorylated by glycerol kinase in
the presence of ATP andMg+2 ions. Glycerol-3-P is oxidized by glycerol-3-phosphate oxidase
(GPO) in the presence of oxygen into dihydroxyacetone phosphate and hydrogen peroxide.
A colored product is produced after reaction of hydrogen peroxide with 4-aminoantipyrine
and phenol-derivative in the presence of the peroxidase. Absorbance wasmeasured at 500 nm
(Bucolo and David, 1973).
Fecal cholesterol analysis
Fecal cholesterol analysis was performed from feces of rats after four weeks of treatment or at
the end of bioassay for lipid profile changes. Fecal cholesterol analysis was conducted by the
Lieberman-Burchard method (Plummer, 1977).
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Cholesterol absorption inhibition test
The cholesterol absorption inhibition test was conducted in six groups of rats with 3 rats per
group. The treatment of PRF was in accordance with bioassay for lipid profile changes; five
groups of rats were treated with PRF 0, 10, 20, 30, and 40 mg/kg body weight, respectively.
All groups were normal rats and were force fed 80 mg cholesterol/kg body weight simultane-
ously with PRF force feeding. Blood was taken retro-orbitally at hours 0, 1, 2, 3, and 4 after
cholesterol and PRF feeding and then analyzed for blood serum total cholesterol.
Data analysis
Data were stated as mean ± standard deviation from the average of six rats per group (three
rats per group for the cholesterol absorption inhibition test). This experiment used a nested
design, and the data were analyzed for analysis of variance (α = .05) and least significant
difference test if there was a significant effect of doses. Statistical analysis was performed using
Minitab 7.0.
Results and discussion
PFAD and PRF characteristics
Data in Table 1 show that PFAD had high free fatty acids of 87.83%; PRF had free fatty acids
of 14.40%. Free fatty acids of PRF were an impurity that ideally should be eliminated during
low-temperature solvent crystallization in PRF preparation. Both PFAD and PRF revealed
low oxidation levels, indicated by peroxide value as an indicator of primary oxidation and
anisidine value as an indicator of secondary oxidation. The p-anisidine value of PRF was
higher than that of PFAD, possibly due to accumulation of lowmolecular secondary oxidation
products in PRF. The peroxide value of PFAD was higher than that of PRF because peroxides
are primary oxidation products that usually have high molecular weight and dissolve in
solvent during low-temperature solvent crystallization; thus, they did not accumulate well in
PRF.
PRF had high phytosterol content of 18.31% compared to PFAD, which only contained
phytosterols of 0.75%. Other components in PRF are not known yet. The study by Moreau
et al. (2009) showed that phytosterol content of crude corn fiber oil was 8.79%, refined corn
fiber oil was 2.40%, and refined corn kernel oil was 1.11%; commercial corn oil had phytos-
terol content of 0.84%. Jiang and Wang (2005) reported that by-products of cereal contained
phytosterols of 9.35 mg/g oil. Phytosterol content of some types of oil varies depending on
their plant sources: mustard (64 mg/g), corn (23 mg/g), soybean (9 mg/g), rapeseed (5 mg/g),
Table . Characteristics of palm fatty acid distillate and phytosterol-rich fraction.
Characteristic PFAD PRF
Free fatty acids (%) . .
Peroxide value (meq/kg) . .
p-anisidine value . .
Phytosterols (%) . .
β-sitosterol (%) . .
Stigmasterol (%) . .
Campesterol (%) . .
Yield (%) — .
PFAD= palm fatty acid distillate; PRF= phytosterol-rich fraction.
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and coconut (0.8 mg/g) (Sabir et al., 2003). In general, vegetable oils contain phytosterols of
1–5 g/kg, except rice bran oil, which has phytosterols of 30 g/kg (Hoed et al., 2006).
Predominant phytosterols of PFAD and PRF were β-sitosterol and stigmasterol, respec-
tively. This difference presumably was due to different solubility and melting point of
each phytosterol during low-temperature solvent crystallization in PRF preparation. The β-
sitosterol content of PRF (Table 1) was higher than that of other phytosterol sources such as
sunflower oil (1,232–1,474 ppm) and olive oil (1,472–1,678 ppm) (Than et al., 2006). Phytos-
terol concentration in soybean oil deodorizer distillate was 6%–10%; PFAD had phytosterols
of 0.04%–0.75% (Khatoon et al., 2010; Estiasih et al., 2013).
The yield of PRF based on PFAD was 0.06%, which indicated only 600 mg of PRF was
obtained from 1 kg of PFAD. The low yield of PRF was suggested due to low unsaponifiable
matter of PFAD, indicated by high free fatty acids of 87.83%. Benites et al. (2009) reported that
free fatty acids in distillate deodorizer of soybean oil was 53%; Estiasih et al. (2013) reported
that PFADs from several palm oil refineries had free fatty acids of 85%–93%.
Lipid profile changes
Lipid profile changes after PRF feeding are shown in Table 2. The decrease of total choles-
terol, triglyceride, and LDL cholesterol, and the increase of HDL cholesterol levels were the
highest in a PRF dose of 40 mg/kg/day (Figure 1): 131.56 mg/dL; 75.20 mg/dL; 107.79 mg/dL;
57.42mg/dL, respectively. Higher PRF doses resulted in greater decreases of blood serum total
Figure . Blood serum lipid proﬁle changes of group of rats treated by various doses of phytosterol-rich
fraction (PRF) for  weeks. (a) Total cholesterol; (b) triglyceride; (c) low-density lipoprotein (LDL) cholesterol;
(d) high-density lipoprotein (HDL) cholesterol.
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Table . Lipid proﬁle changes of dyslipidemia rats during  weeks of PRF feeding at various doses.
Cholesterol total (mg/dL)
Hypercholesterolemia group+ PRF (mg/kg/day)
Week Normal     
 . ± . b . ± . c . ± . a . ± . a . ± . a . ± . a
 . ± . ab . ± . c . ± . b . ± . b . ± . b . ± . b
 . ± . a . ± . b . ± . c . ± . c . ± . c . ± . c
 . ± . a . ± . ab . ± . c . ± . d . ± . d . ± . d
 . ± . a . ± . a . ± . d . ± . c . ± . e . ± . e
Triglyceride (mg/dL)
Hypercholesterolemia group+ PRF (mg/kg/day)
Week Normal     
 . ± . d . ± . b . ± . a . ± . a . ± . a . ± . a
 . ± . cd . ± . b . ± . b . ± . b . ± . b . ± . b
 . ± . bc . ± . ab . ± . c . ± . c . ± . c . ± . c
 . ± . ab . ± . a . ± . d . ± . d . ± . d . ± . d
 . ± . a . ± . a . ± . d . ± . e . ± . e . ± . e
LDL cholesterol (mg/dL)
Hypercholesterolemia group+ PRF (mg/kg/day)
Week Normal     
 . ± . c . ± . c . ± . a . ± . a . ± . a . ± . a
 . ± . c . ± . bc . ± . b . ± . b . ± . b . ± . b
 . ± . b . ± . ab . ± . c . ± . c . ± . c . ± . c
 . ± . b . ± . a . ± . d . ± . d . ± . d . ± . d
 . ± . a . ± . a . ± . e . ± . e . ± . e . ± . e
HDL cholesterol (mg/dL)
Hypercholesterolemia Group+ PRF (mg/kg/day)
Week Normal     
 . ± . a . ± . a . ± . d . ± . d . ± . e . ± . e
 . ± . a . ± . ab . ± . c . ± . c . ± . d . ± . d
 . ± . b . ± . bc . ± . c . ± . c . ± . c . ± . c
 . ± . bc . ± . c . ± . b . ± . b . ± . b . ± . b
 . ± . c . ± . c . ± . a . ± . a . ± . a . ± . a
Data in the same column that have the same letter are not signiﬁcantly diﬀerent at α = .. PRF = phytosterol-rich fraction;
LDL= low-density lipoprotein; HDL= high-density lipoprotein.
cholesterol, triglyceride, and LDL cholesterol levels. The higher PRF doses made the higher
HDL cholesterol level rise (Figure 1d). After four weeks of PRF feeding of 40 mg/kg/day, the
lipid profile of dyslipidemia rats was approximately normal. Meanwhile, dyslipidemia rats fed
only AIN-93Mwithout PRF treatment still showed dyslipidemia condition, indicated by high
total cholesterol, LDL cholesterol, and triglyceride levels and lowHDL cholesterol levels. PRF
doses significantly (α = .05) affected the lipid profiles of dyslipidemia rats, as did duration of
PRF treatment (Figure 1).
Figure 1 shows that lipid profiles tended to improve every week, and it was suggested
that longer PRF treatment would result in greater lipid profile improvement. The trend of
lipid profile changes was almost linear with an increase for HDL cholesterol and decreases
for total cholesterol, triglyceride, and LDL cholesterol. However, there is a variation of R2
(0.73–0.98, data not shown) between duration of treatment and blood lipid level. Duration of
treatment affected lipid profile changes significantly (α = .05). The highest linear correlation
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with duration of treatment was found in a PRF dose of 40 mg/kg/day for all blood lipid.
This means the change of lipid profile at high dose was time dependent. After four weeks of
treatment, the condition of approximately normal was found in PRF dose of 40 mg/kg/day.
It is highly possible that lower doses would result in lipid profiles similar to normal in longer
PRF treatment (more than four weeks).
Phytosterols are well known to effectively inhibit cholesterol absorption from food and
bile acid in the digestive tract by several mechanisms: cholesterol replacement in micelles,
decreasing cholesterol solubility in digestive tract, and reducing cholesteryl ester synthesis in
intestine. Phytosterols have high hydrophobicity and low solubility, but have higher affinity to
micelles than cholesterol. Therefore, phytosterols have the ability to replace cholesterol from
intraluminal micelles; thus, cholesterol was discarded into feces (Ikeda et al., 1989; Ling and
Jones, 1995). In the intestine, phytosterols solubilize in themicelle form, and thismicelle inter-
acts with brush border and is transferred into enterocyte. Phytosterols are incorporated into
chylomicron and secreted in lymph through the biliary system (John et al., 2007). Phytosterols
can reduce cholesterol absorption 30%–50% (Jones et al., 2000). Co-crystallization of phytos-
terols and cholesterol in the gastrointestinal tract reduces cholesterol uptake due to lower
solubility of crystal compared to cholesterol alone (Garti et al., 2006). The study by Ling and
Jones (1995) showed that β-sitosterol increased bile acid micelles affinity in high concentra-
tion of sterols. Phytosterols reduce cholesteryl ester synthesis in enterocyte through inhibition
of acyl-coenzymeA cholesterol acyltransferase (ACAT) activity (Ikeda et al., 1989). Therefore,
ACAT activity inhibition increases intracellular free cholesterol concentration, which reduces
intestinal cholesterol uptake (Krauss et al., 2000).
According to Mel’nikov et al. (2003), phytosterols have a similar structure to cholesterol.
Furthermore, Berry (2004) stated that phytosterols reduce cholesterol absorption because
they compete with cholesterol and phytosterols show higher affinity (Normén et al., 2000).
Cholesterol and phytosterol competition occurs in the digestive tract in the esterification
stage, or phytosterols partially inhibit lipoprotein binding to cholesterol for transportation
from intestinal mucosa. This inhibition increases fecal cholesterol secretion. The study by
Chen et al. (2010) showed that phytosterol intake of 2 g/kg feed for five weeks reduced hep-
atic cholesterol 40%, cholesterol in the aorta 31%, and renal cholesterol 19%.
PRF doses significantly affected blood serum total cholesterol level reduction (Figure 1a).
According to Hendriks et al. (1999) and Volpe et al. (2001), a phytosterol dose of 0.8 g/day
did not significantly reduce serum total cholesterol and LDL cholesterol levels. The sug-
gested dose was 2–3 g/day (FDA, 2000; Lichtenstein and Deckelbaum, 2001), but doses
more than 3 g/day have a slight effect in cholesterol reduction (Scientific Committee on
Food of the EU, 2003). Figure 1b shows that PRF feeding effectively decreased blood serum
triglyceride level. According to Lamarch et al. (1999), increasing plasma triglyceride is
strongly related to decreasing size of predominant LDL. Bile acid secretion due to phy-
tosterol intake affected blood serum triglyceride. Bile acid influences triglyceride absorp-
tion, and presumably bile acid secretion is higher in the existence of phytosterols in the
intestine.
PRF decreased blood serum LDL cholesterol level even in low dose (Figure 1c). As
previously explained, this decrease was related to cholesterol absorption and ACAT activity
inhibition. This finding is in accordance to that reported by Turley and Dietschy (2003)
that phytosterol intake reduced LDL cholesterol due to cholesterol synthesis and absorption
inhibition. Cohen (2008) stated that phytosterols also inhibit bile cholesterol reabsorption
in the colon. Phytosterols have a similar structure to cholesterol but are more hydrophobic;
therefore, they can replace cholesterol from micelles. Phytosterols enter enterocytes and will
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be resecreted into lumen more efficiently. Kamal-Eldin and Moazzami (2009) revealed that
intake of phytosterols or phytostanols 1–2 g/day reduced LDL cholesterol level 10%–20%.
Blood serum HDL cholesterol increase in dyslipidemia rats fed PRF was related to reduc-
tion in LDL cholesterol level (Figure 1d). Increasing PRF doses enhanced HDL cholesterol
level. HDL has a role in cholesterol transportation from the bloodstream to the liver. Choles-
terol is not soluble in blood; thus, this compound is transported in the form of lipoprotein
such as HDL cholesterol. Excessive cholesterol in the liver will be eliminated through bile
acid secretion. Cholesterol transportation into the liver is important to maintain cholesterol
balance (Cohen, 2008). LDL cholesterol level reduction decreased cholesterol transportation
from the liver to the blood resulting in HDL cholesterol level increase. From the liver, choles-
terol is transported into the gall bladder to be converted into bile acid and then secreted into
feces.
Cholesterol absorption inhibition and fecal cholesterol concentration
In this experiment, PRF (dosages 0–40 mg/kg body weight) and cholesterol (80 mg/kg body
weight) were concomitantly force fed to five groups of rats. The aim of this treatment was
to learn the effect of phytosterol feeding on cholesterol absorption inhibition. PRF delayed
the increase of blood serum total cholesterol level at hours 1 and 2 after feeding (Figure 2).
At PRF dosage of 0 mg/kg body weight, 2 hours after feeding, blood serum total cholesterol
level remained constant. At PRF dosage of 10 mg/kg body weight, blood serum total choles-
terol level decreased slightly at hour 4. However, total cholesterol level decreased 2 hours after
feeding at higher doses of PRF (dose 30 and 40 mg/kg body weight). The sharp increase of
total cholesterol level after feeding was found in PRF dosage of 0 mg/kg. This phenomenon
indicated that PRF had the ability to delay blood serum total cholesterol level rise after choles-
terol ingestion. Increasing the dosage of PRF caused decreasing blood serum total cholesterol
level rise, meaning the higher the PRF dose, the lower the blood serum total cholesterol level
rise after cholesterol ingestion.
These facts show that PRF inhibited cholesterol absorption even though cholesterol
and phytosterols were ingested concomitantly. This finding indicates that formulating PRF
Figure . Blood serum total cholesterol level rise after feeding as aﬀected by doses of phytosterol-rich frac-
tion (PRF).
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into cholesterol-containing food products might inhibit cholesterol absorption. Moreover,
phytosterol-enriched food products can be formulated to inhibit cholesterol absorption, even
more for cholesterol-containing products because phytosterols prevent cholesterol absorp-
tion in the intestine (Tasan et al., 2006). The human study by Shin et al. (2005) showed that
phytosterols administered as phytosterol-emulsifier vehicle significantly reduced cholesterol
absorption by 23.3% at a dose of 300 mg and by 32.0% at a dose of 500 mg compared with
the placebo, indicatingmicellar phytosterols reduced cholesterol absorption effectively at very
low doses. Phytosterols used in that study were formulated in nanoparticles and thus can be
readily dispersed in water, providing a flexible delivery system for various food products such
as beverages, confections, and cooking oil.
Inhibition of cholesterol absorption was also proved by measuring fecal cholesterol con-
centration after four weeks of PRF feeding. Figure 3 shows that PRF inhibited cholesterol
absorption as indicated by the fact that fecal cholesterol concentration of rats treated with
PRF was higher than that of the normal group (without PRF feeding). The increase in PRF
doses resulted in increasing fecal cholesterol concentration, indicating that the ability of PRF
to inhibit cholesterol absorption also increased. This finding was in accordance with the result
of the cholesterol absorption inhibition test. Increasing fecal cholesterol was related to the
ability of phytosterols to inhibit cholesterol absorption in the intestine; thus, cholesterol accu-
mulated in the caecal digesta and was secreted into feces. High fecal cholesterol concentration
indicated low cholesterol absorption in the digestive tract (Lupton and Turner, 2000).
The findings of this research show that PRF effectively improved lipid profile in dyslipi-
demia condition. Further research is needed to prove the effect of PRF on humans. The best
PRF dosage from this study was 40 mg/kg body weight); this dosage should be converted if
it is used for clinical study in humans. According to Shin et al. (2010), the significance of
dose conversion is based on body surface area and starting dose estimation for clinical trials.
The body surface area seems to have good correlation among species with several parame-
ters, including oxygen utilization, caloric expenditure, basal metabolism, blood volume, and
circulating plasma protein.
Figure . Fecal cholesterol of rats treated by various doses of phytosterol-rich fraction (PRF) after  weeks of
PRF feeding.
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Conclusion
PRF improved blood serum lipid profile by decreasing total cholesterol, triglyceride, and
LDL cholesterol levels and increasing HDL cholesterol level. The doses of PRF significantly
affected blood serum lipid profile as did duration of PRF treatment. Rats fed PRF at a dose of
40 mg/kg/day reached a blood serum lipid profile similar to that of the normal group. PRF
inhibited cholesterol absorption, which delayed blood serum total cholesterol rise. This was
indicated by the increase of blood serum total cholesterol level after ingestion of cholesterol
and PRF concomitantly. Blood serum total cholesterol level after cholesterol ingestion was
affected by PRF dose. Higher doses of PRF were more effective in inhibiting blood serum
total cholesterol rise. Cholesterol absorption inhibition was also indicated by fecal choles-
terol concentration after PRF feeding. PRF doses affected fecal cholesterol concentration, and
higher fecal concentrationswere found in higher PRF doses. PRFmay be of use in phytosterol-
enriched foods for cholesterol-containing products.
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